Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment.

Although there was a trend for treatment across groups, this failed to reach statistical significance (Figure 6f,g ; F (2,28) = 3.28, p = .053) but it was notable that both sham and GW2580‐treated hypoperfused mice show reduced escape latencies compared to vehicle‐treated hypoperfused mice.

also in 6,035 other papers